Lineage Cell Therapeutics
LCTX
#8691
Rank
S$0.16 B
Marketcap
$0.76
Share price
11.16%
Change (1 day)
-47.22%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total assets

Total assets on the balance sheet as of September 2024 : S$0.13 Billion

According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are S$0.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$0.13 B-19.52%
2022-12-31S$0.16 B-29.74%
2021-12-31S$0.23 B65.23%
2020-12-31S$0.14 B-15.58%
2019-12-31S$0.16 B21.81%
2018-12-31S$0.13 B-40.06%
2017-12-31S$0.23 B12.29%
2016-12-31S$0.20 B54.1%
2015-12-31S$0.13 B35.29%
2014-12-31S$98.96 M35.31%
2013-12-31S$73.14 M101.05%
2012-12-31S$36.37 M-38.71%
2011-12-31S$59.35 M-13.51%
2010-12-31S$68.62 M263.87%
2009-12-31S$18.85 M1173.54%
2008-12-31S$1.48 M487.69%
2007-12-31S$0.25 M-74.74%
2006-12-31S$0.99 M-69.42%
2005-12-31S$3.26 M31.38%
2004-12-31S$2.48 M36.35%
2003-12-31S$1.82 M-29.87%
2002-12-31S$2.59 M-27.77%
2001-12-31S$3.59 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$0.40 B 212.72%๐Ÿ‡บ๐Ÿ‡ธ USA